AAT Recombinant Antibody

Applications

  • WB
  • IP
  • ICC/IF

Reactivity

  • Human
Overview
Catalog # bsm-61403r
Product Name AAT Recombinant Antibody
Applications
WB IP ICC/IF
Reactivity Human
Specifications
Conjugation Unconjugated
Host Rabbit
Source A synthesized peptide derived from human SERPINA1
Clonality Recombinant
Isotype IgG
Concentration 1mg/ml
Purification purified by Protein A.
Storage Buffer 10mM phosphate buffered saline(pH 7.4) with 150mM sodium chloride, 0.05% BSA, 0.02% Proclin300 and 50% glycerol.
Storage Condition Shipped at 4C. Store at -20C for one year. Avoid repeated freeze/thaw cycles.
Target
Gene ID 5265
Swiss Prot P01009
Subcellular location Secreted, Extracellular matrix
Synonyms A1A; A1AT; AAT; PI; PI1; PRO2275; alpha1AT; nNIF; Spi1; A1AT_HUMAN; SERPINA1; Alpha-1 protease inhibitor; Alpha-1-antiproteinase; Serpin A1; A1AT1_MOUSE; Serpina1a; Alpha-1 protease inhibitor 1; Serine protease inhibitor 1-1; Serine protease inhibitor A1a (Serpin A1a); Dom1; Spi1-1; A1AT_RAT; Alpha-1-antitrypsin; Alpha-1-proteinase inhibitor; serpin family A member 1; serine (or cysteine) proteinase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1; serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1; protease inhibitor 1; anti-elastase; alpha-1 antitrypsin; alpha-1 proteinase inhibitor
Background Inhibitor of serine proteases. Its primary target is elastase, but it also has a moderate affinity for plasmin and thrombin. Irreversibly inhibits trypsin, chymotrypsin and plasminogen activator. The aberrant form inhibits insulin-induced NO synthesis in platelets, decreases coagulation time and has proteolytic activity against insulin and plasmin.
Application Dilution
WB 1:300-5000
IP IHC-P1:200-400
ICC/IF IHC-F1:100-500